Abstract
Iron is the most abundant trace element in the human body. It is well known that iron is an important component of hemoglobin involved in the transport of oxygen. As a component of various enzymes, it participates in the tricarboxylic acid cycle and oxidative phosphorylation. Iron in the nervous system is also involved in the metabolism of catecholamine neurotransmitters and is involved in the formation of myelin. Therefore, iron metabolism needs to be strictly regulated. Previous studies have shown that iron deficiency in the brain during infants and young children causes mental retardation, such as delayed development of language and body balance, and psychomotor disorders. However, if the iron is excessively deposited in the aged brain, it is closely related to the occurrence of various neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, and Friedreich’s ataxia. Therefore, it is important to fully study and understand the mechanism of brain iron metabolism and its regulation. On this basis, exploring the relationship between brain iron regulation and the occurrence of nervous system diseases and discovering new therapeutic targets related to iron metabolism have important significance for breaking through the limitation of prevention and treatment of nervous system diseases. This review discusses the complete research history of iron and its significant role in the pathogenesis of the central nervous system (CNS) diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andersen HH, Johnsen KB, Moos T (2014) Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration. Cell Mol Life Sci 71:1607–1622
Appleton TC, Morgan E, Baker E (1971) A morphological study of transferrin uptake by reticulocytes. In: Trávníèek T, Neuwirt J (eds) The regulation of erythropoiesis and haemoglobin synthesis. Universita karlova, prague, pp 310
Birkmayer W, Hornykiewicz O (1961) The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia. Wien Klin Wochenschr 73:787–788
Busacchi V (1958) Vincenzo Menghini and the discovery of iron in the blood. Bull Sci Med (bologna) 130:202–205
Charcot JM (1872) De la paralysie agitante. In: Oeuvres Complètes (t1) Leçons sur les maladies du système nerveux, pp 155–188. Delahaye A, Paris: In: English: Charcot JM. 1877. On Parkinson’s disease. In Lectures on diseases of the nervous system delivered at the Salpêtrière (trans: Sigerson G). New Sydenham Society, London, pp 129–156
Chen H, Attieh ZK, Syed BA, Kuo YM, Stevens V, Fuqua BK, Andersen HS, Naylor CE, Evans RW, Gambling L et al (2010) Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells. J Nutr 140:1728–1735
Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP et al (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28:350–354
Conrad ME Jr, Crosby WH (1963) Intestinal mucosal mechanisms controlling iron absorption. Blood 22:406–415
Conrad S, Genth H, Hofmann F, Just I, Skutella T (2007) Neogenin-RGMa signaling at the growth cone is bone morphogenetic protein-independent and involves RHoA, ROCKk, and PKC. J Biol Chem 282:16423–16433
Deane R, Zheng W, Zlokovic BV (2004) Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain. J Neurochem 88:813–820
Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403:776–781
Drysdale JW, Munro HN (1965) Failure of actinomycin D to prevent induction of liver apoferritin after iron administration. Biochim Biophys Acta 103:185–188
Ehringer H, Hornykiewicz O (1960) Verteilung von noradrenalin and dopamin im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klin Wschr 38:1126–1239
Fenton HJH (1876) On a new reaction or tartaric acid. Chemical News 33:190
Fenton HJH (1893) The oxidation of tartaric acid in presence of iron. Chem Soc Proc 9:113
Fineberg RA, Greenberg DM (1955) Ferritin biosynthesis II. Acceleration of synthesis by the administration of iron. J Biol Chem 214:97–106
Finch CA (1959) Body iron exchange in man. J Clin Invest 38:392–396
Fontés G, Thivolle I (1925) Sur la teneur du sérum en fer non hémoglobinique et sur sa diminution au cours de l’anémie expérimentale. Compt Rend Soc Biol 96:687
Gowers WR (1899) Paralysis agitans. In: Allbutt A, Rolleston T (eds) A system of medicine. Macmillan, London, pp 156–178
Guo B, Phillips JD, Yu Y, Leibold EA (1995) Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J Biol Chem 270:21645–21651
Hahn PF, Bale WF, Ross JF, Balfour WM, Whipple GH (1943) Radioactive iron absorption by gastrointestinal tract: influence of anemia, anoxia, and antecedent feeding distribution in growing dogs. J Exp Med 78:169–188
Hahn P, Qian Y, Dentchev T, Chen L, Beard J, Harris ZL et al (2004) Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A 101:13850–13855
Halliwell B, Gutteridge JM (1984) Role of iron in oxygen radical reactions. Methods Enzymol 105:47–56
Hentz MW, Kuhn LC (1996) Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A 93:8175–8182
Hentze MW, Muckenthaler MU, Galy B, Camaschella C (2010) Two to tango: regulation of mammalian iron metabolism. Cell 142:24–38
Holmberg CG, Laurell CB (1945) Studies on the capacity of serum to bind iron—a contribution to our knowledge of the regulation mechanism of serum iron. Acta Physiol Scand 10:307
Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O’Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P (2012) Donepezil and meantime for moderate-to-severe Alzheimer’s disease. N Engl J Med 366:893–903
Hornykiewicz O (2002) Dopamine miracle: from brain homogenate to dopamine replacement. Mov Disord 17:501–508
Holtz P, Heise R, Lüdtke K (1938) Fermentative degradation of l-dioxyphenylalanine (dopa) by kidney. Naunyn-Schmiedeberg’s Arch. Pharmacol 191:87–118
Jandl JH, Katz JH (1963) The plasma-to-cell cycle of transferrin. J Clin Invest 42:314–326
Kasarskis EJ, Tandon L, Lovell MA, Ehmann WD (1995) Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study. J Neurol Sci 130:203–208
Ke Y, Qian ZM (2007) Brain iron metabolism: neurobiology and neurochemistry. Prog Neurobiol 83:149–173
Leibold EA, Munro HN (1988) Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy- and light-subunit mRNAs. Proc Natl Acad Sci U S A. 85:2171–2175
Lecanu LR, l’hématosine de (1830) O matière colorante du sang. Ann Chim 45:5–27
Lecanu LR (1831) Nouvelle recherches sur le sang. Ann Chim 48:308–327
Li X, Jankovic J, Le W (2011) Iron chelation and neuroprotection in NDs. J Neural Trans 118:473–477
Manyam BV (1990) Paralysis agitans and levodopa in “Ayurveda”: ancient Indian medical treatise. Mov Disord 5(1):47–48
Malecki EA, Devenyi AG, Beard JL, Connor JR (1999) Existing and emerging mechanisms for transport of iron and manganese to the brain. J Neurosci Res 56:113–122
McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5:299–309
McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, BarlowD Bomford A (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291:1755–1759
Mayajima H (2003) Aceruloplasminemia an iron metabolic disorder. Neuropathology 23:345–350
Monarde N (1925) Joyful newes out of the newe founde worlde. New York
Morgan EH, Appleton TC (1969) Autoradiographic localization of 125-I-labelled transferrin in rabbit reticulocytes. Nature 223:1371–1372
Mccance RA, Widdowson EM (1938) The absorption and excretion of iron following oral and intravenous administration. J Physiol 94:148–154
Nicolas G, Bennoun M, Devaux I et al (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A. 98(15):8780–8785
Oshiro S, Kawahara M, Kuroda Y, Zhang C, Cai Y, Kitajima S, Shirao M (2000) Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells. Biochim Biophys Acta 1502:405–414
Owen D, Kühn LC (1987) Noncoding 3′ sequences of the transfer in receptor gene are required for mRNA regulation by iron. EMBO J 6:1287–1293
Parkinson J (1817) An essay on the shaking palsy. Whittingham and Rowland for Sherwood, Needly and Jones, London
Pollycove M, Mortimer R (1961) The quantitative determination of iron kinetics and hemoglobin synthesis in human subjects. J Clin Invest 40:753–782
Qian ZM, Chang YZ, Zhu L, Yang L, Du JR, Ho KP et al (2007) Development and iron-dependent expression of hephaestin in different brain regions of rats. J Cell Biochem 102:1225–1233
Rouault TA (2006) The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2:406–414
Schade AL, Caroline I (1944) Raw hen egg white and the role of iron in growth inhibition of Shigella dysenteriae, Staphylococcus aureus, Escherichia coli and Saccharomyces cerevisiae. Science 100:14–15
Santa-Maria I, Hernández F, Del Rio J, Moreno FJ, Avila J (2007) Tramiprosate, a drug of potential interest for the treatment of Alzheimer’s disease, promotes an abnormal aggregation of tau. Mol Neurodegener 6:17
Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial Memantine Study Group. JAMA 291(3):317–324
Troadec MB, Warner D, Wallace J et al (2011) Targeted deletion of the mouse Mitoferrin1 gene: from anemia to protoporphyria. Blood 117(20):5494–5502
Vanotti A, Delachaux A (1949) iron metabolism and its clinical significance. Grune & Stratton, New York
Vivot RM, Goitia B, Usach V, Setton-Avruj PC (2013) DMT1 as a candidate for non-transferrin-bound iron uptake in the peripheral nervous system. BioFactors 39:476–484
Vulpe CD, Kuo YM, Murphy TL, CowleyL Askwith C, Libina N, Gitschier J, Anderson GJ (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21:195–199
Wächtershäuser G (1990) Evolution of the first metabolic cycles. Proc Natl Acad Sci U S A 87:200–204
Wächtershäuser G (2000) Origin of life. Life as we don’t know it. Science 289:1307–1308
Wang SM, Fu LJ, Duan XL, Crooks DR, Yu P, Qian ZM, Di XJ, Li J, Rouault TA, Chang YZ (2010) Role of hepcidin in murine brain iron metabolism. Cell Mol Life Sci 67(1):123–133
You LH, Yan CZ, Zheng BJ, Ci YZ, Chang SY, Yu P, Gao GF, Li HY, Dong TY, Chang YZ (2017) Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis. Cell Death Dis 8(3):e2676
Zahringer J, Baliga BS, Munro HN (1976) Novel mechanism for translational control in regulation of ferritin synthesis by iron. Proc Natl Acad Sci USA 73:857–861
Zorzi G, Zibordi F, Chiapparini L, Bertini E, Russo L, Piga A et al (2011) Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. Mov Disord 26:1756–1759
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Thirupathi, A., Chang, YZ. (2019). Brain Iron Metabolism and CNS Diseases. In: Chang, YZ. (eds) Brain Iron Metabolism and CNS Diseases. Advances in Experimental Medicine and Biology, vol 1173. Springer, Singapore. https://doi.org/10.1007/978-981-13-9589-5_1
Download citation
DOI: https://doi.org/10.1007/978-981-13-9589-5_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9588-8
Online ISBN: 978-981-13-9589-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)